Sartorius combines with Stedim

Laboratory equipment provider Sartorius AG

Register for free to listen to this article
Listen with Speechify
GÖTTINGEN, Germany—Laboratory equipment provider Sartorius AG announced a binding agreement with French biopharmaceutical supplier Stedim Biosystems SA that will see it take a majority position with the smaller company and fold its biotechnology division into Stedim. The combined company will be renamed Sartorius Stedim Biotech SA.
"In establishing this alliance between two companies focused on the same customers and with complementary product portfolios, our first objective will be to implement a strategic and an industrial project with an impact much greater than the sum of the two parts," said Bernard Lemaitre, Stedim chairman. "Once combined, Sartorius Biotechnology and Stedim have the realistic ambition of forming a worldwide market leader for single-use based technologies over the next five years. No other group can offer the biopharmaceutical market such a broad range of solutions." 
As indicated, the combined company hopes to grab a larger share of the growing biosupply marketplace, particularly in the single-use consumables sector. In 2006, Stedim earned €91.4 million in sales, almost half of which were generated in the United States.

Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

DDN July 2024 Magazine Issue

Latest Issue  

• Volume 20 • Issue 4 • July 2024

July 2024

July 2024 Issue